The Fralin Biomedical Research Institute at VTC’s Center for Transformative Research on Health Behaviors is supporting its first three pilot research projects to tackle health issues caused by lifestyle diseases.
A group of genes that has been largely ignored by scientists could play critical roles in atherosclerosis (hardening of the arteries), inflammation, and likely obesity and other metabolic diseases, new research suggests.
Researchers at the UVA School of Medicine have made a discovery about human papillomavirus (HPV) that could lead to new treatments for cervical cancer and other cancers caused by the virus.
A unique partnership between a Virginia Tech scientist and a University of Virginia oncologist could result in a solution to reduce discomfort during cancer treatment for women.
A husband-and-wife team at the UVA Cancer Center have been awarded $1.8 million to improve radiation therapy and breast surgery for patient with early-stage breast cancer.
National healthcare publication Becker’s Hospital Review has named the University of Virginia Cancer Center at UVA Medical Center to its 2018 list of 100 hospitals and health systems with great oncology programs.
A new innovation in cancer research will enable scientists to understand the complex causes of the disease with unprecedented speed and sophistication.
A new telehealth partnership between Novant Health UVA Health System Culpeper Medical Center and UVA Health System will enable Culpeper-area patients to get easier access to UVA’s heart and vascular experts.
A UVA School of Medicine researcher is developing a two-fisted, antibody-based approach to destroy deadly ovarian cancer – an approach he believes could also be modified to kill breast, prostate and other solid tumors.
For the third consecutive year, U.S. News & World Report has ranked UVA Medical Center as the No. 1 hospital in Virginia. The publication’s 2018-2019 “Best Hospitals” guide also recognizes nine UVA specialties for adults among the best in the U.S.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.